Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 30, 2018

View Archived Issues

MicroRNA-31-5p levels defines disease course and clinical outcome in Crohn's disease

Inhibition of hippocampal TLR2 signaling prevents Alzheimer's disease development

Dual GLP-1/GIP agonist LY-3298176 superior to GLP-1 agonist dulaglutide for diabetes control

NEO-PV-01 induces broad and durable immune responses in patients with metastatic cancers

GC-1118 shows promising efficacy in patients with CRC resistant to prior EGFR antibody therapy

Activating toxin early mitigates C. difficile infection

Forcing mutated cells to grow up

New ROCK2 inhibitor REDX-10178 shows promise for the treatment of kidney injury

FDA approves Xyrem for cataplexy or excessive daytime sleepiness in pediatric narcolepsy patients

FDA approves Bijuva for moderate to severe hot flashes due to menopause

Xtandi granted approval in Europe for high-risk nonmetastatic castration-resistant prostate cancer

Promising topline phase III data presented for Baxdela for treatment of CABP

NEC and Transgene sign MOU for cancer immunotherapy collaboration

Spark Therapeutics presents post-hoc analyses of phase III Luxturna data

Clearside Biomedical presents additional phase III data for Xipere in uveitic macular edema

Phase III study of daratumumab in front-line multiple myeloma meets primary endpoint

FDA allows IND for Athenex's oral eribulin

TMPRSS11E gene identified as a novel biomarker of smoking-related traits in Europeans

CS-1001 demonstrates promising preliminary safety and antitumor activity in phase I study

Preliminary data presented from phase I/II study of AGEN-1884 in combination with AGEN-2034

hNIS transgenic mouse as a resource of stem cells innately enabling in vivo cell tracking

CTAD 2018: Change in target? Maybe. Change in culture? Yes

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...